Hutai International Won for “Megatrend Deal of the Year” at FinanceAsia Achievement Awards 2020

Recently, the result of FinanceAsia Achievement Awards 2020 was announced, with close to 900 submissions across APAC, recognising excellence in bringing issuers and investors together in the development of Asia's financial markets during 2020, an incredibly difficult year.

Huatai International was involved in the winners of “Megatrend Deal of the Year (healthcare) - RemeGen’s HK$3.99 billion ($514 billion) Hong Kong IPO” and acted as the Joint Sponsor, Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager for the deal.

RemeGen Limited (9995.HK) was successfully listed on the Main Board of the Hong Kong Stock Exchange On Nov 9 2020. With pre-IPO valuation of nearly US$1.4 billion, RemeGen raised HK$3.99 billion, making it the largest IPO of Chapter 18A biotech companies (not including dual listing).